A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder
10.4088/JCR.12m08093
Saved in:
Main Authors: | Cusin, C., Iovieno, N., Iosifescu, D.V., Nierenberg, A.A., Fava, M., Rush, A.J., Perlis, R.H. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110478 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder
by: Perlis, R.H., et al.
Published: (2014) -
A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints
by: Helen Lavretsky, et al.
Published: (2020) -
Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
by: Ratti, E., et al.
Published: (2014) -
Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
by: Zhu, H., et al.
Published: (2014) -
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
by: Davis, L.L., et al.
Published: (2014)